130 related articles for article (PubMed ID: 25351720)
1. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.
Wang X; Breeze A; Kulka M
Cancer Immunol Immunother; 2015 Feb; 64(2):249-58. PubMed ID: 25351720
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids impair in vivo interferon- gamma responsiveness via diminished receptor signaling.
Irons R; Fritsche KL
J Infect Dis; 2005 Feb; 191(3):481-6. PubMed ID: 15633108
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
[TBL] [Abstract][Full Text] [Related]
5. Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells.
Chung HK; Lee IK; Kang H; Suh JM; Kim H; Park KC; Kim DW; Kim YK; Ro HK; Shong M
Exp Mol Med; 2002 Dec; 34(6):451-61. PubMed ID: 12526087
[TBL] [Abstract][Full Text] [Related]
6. Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice.
Feng C; Keisler DH; Fritsche KL
J Interferon Cytokine Res; 1999 Jan; 19(1):41-8. PubMed ID: 10048767
[TBL] [Abstract][Full Text] [Related]
7. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
8. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
9. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
Lee YJ; Benveniste EN
J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
Fang P; Hwa V; Rosenfeld RG
Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
13. The IL-18 antagonist IL-18-binding protein is produced in the human ovarian cancer microenvironment.
Carbotti G; Barisione G; Orengo AM; Brizzolara A; Airoldi I; Bagnoli M; Pinciroli P; Mezzanzanica D; Centurioni MG; Fabbi M; Ferrini S
Clin Cancer Res; 2013 Sep; 19(17):4611-20. PubMed ID: 23873689
[TBL] [Abstract][Full Text] [Related]
14. The direct effect of IL-12 on tumor cells: IL-12 acts directly on tumor cells to activate NF-kappaB and enhance IFN-gamma-mediated STAT1 phosphorylation.
Su W; Ito T; Oyama T; Kitagawa T; Yamori T; Fujiwara H; Matsuda H
Biochem Biophys Res Commun; 2001 Jan; 280(2):503-12. PubMed ID: 11162546
[TBL] [Abstract][Full Text] [Related]
15. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta.
Hurgin V; Novick D; Rubinstein M
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16957-62. PubMed ID: 12482935
[TBL] [Abstract][Full Text] [Related]
16. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
17. IL-18 is produced by prostate cancer cells and secreted in response to interferons.
Lebel-Binay S; Thiounn N; De Pinieux G; Vieillefond A; Debré B; Bonnefoy JY; Fridman WH; Pagès F
Int J Cancer; 2003 Oct; 106(6):827-35. PubMed ID: 12918059
[TBL] [Abstract][Full Text] [Related]
18. Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes.
Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F
Immunol Lett; 2010 Nov; 134(1):17-25. PubMed ID: 20709103
[TBL] [Abstract][Full Text] [Related]
19. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1/GAS axis on the promoter level.
Bachmann M; Paulukat J; Pfeilschifter J; Mühl H
J Cell Mol Med; 2009 Aug; 13(8B):1987-1994. PubMed ID: 19046253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
